{
  "nctId": "NCT04633551",
  "briefTitle": "Vascular Inflammation and Anti-inflammatory Supplements After Adverse Pregnancy Outcomes",
  "officialTitle": "Supplements to Improve Vascular Inflammation After an Adverse Pregnancy Outcome",
  "protocolDocument": {
    "nctId": "NCT04633551",
    "filename": "Prot_SAP_000.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2020-11-13",
    "uploadDate": "2022-10-04T09:55",
    "size": 159742,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT04633551/document/Prot_SAP_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "SINGLE",
  "enrollmentInfo": {
    "enrollmentCount": 9,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2020-10-01",
    "completionDate": "2022-05-30",
    "primaryCompletionDate": "2021-06-30",
    "firstSubmitDate": "2020-11-06",
    "firstPostDate": "2020-11-18"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Had a singleton pregnancy in the past 3 years that lasted 20 weeks or more\n* Most recent pregnancy was complicated by an APO\n\nExclusion Criteria:\n\n* currently pregnant or breastfeeding,\n* current smoking,\n* active cancer,\n* regular use of NSAIDs, steroidal medications, statins, or other anti-inflammatory supplements,\n* HIV/AIDS,\n* uncontrolled high blood pressure ( \\>160/\\>110 mmHg),\n* unwilling or unable to use a dietary supplement,\n* known sensitivity to resveratrol, curcumin, green tea, or quercetin",
    "healthyVolunteers": true,
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "maximumAge": "45 Years",
    "stdAges": [
      "ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Blood Pressure (mmHg)",
        "description": "Investigators will measure blood pressure in the arm and use applanation tonometry to estimate aortic blood pressure",
        "timeFrame": "1 month"
      },
      {
        "measure": "Arterial Stiffness (m/s)",
        "description": "Arterial stiffness will be measured with pulse wave velocity using applanation tonometry and heart rate",
        "timeFrame": "1 month"
      },
      {
        "measure": "Augmentation Index (%)",
        "description": "Applanation tonometry will be used to describe systolic blood pressure augmentation, a measure of arterial wave reflection intensity.",
        "timeFrame": "1 month"
      },
      {
        "measure": "Endothelial Function (Reactive Hyperemia)",
        "description": "Venous occlusion plethysmography will be used to mease the change in forearm blood flow after a 5-min occlusion",
        "timeFrame": "1 month"
      }
    ],
    "secondary": [
      {
        "measure": "Inflammatory Vascular Biomarkers (pg/dL)",
        "description": "concentrations of circulating adhesion molecules ICAM and VCAM",
        "timeFrame": "1 month"
      },
      {
        "measure": "Acceptability of Intervention (Likert Scales From 1-5; Not Likely at All to Extremely Likely and Free Text Fields)",
        "description": "Surveys regarding opinion and likelihood of taking supplements. Here we report the number of participants who thought supplements were somewhat or extremely useful (Likert score of 4-5) for improving health.",
        "timeFrame": "1 month"
      },
      {
        "measure": "Perception of Intervention (15-20 Minute Interview)",
        "description": "Interviews will be used to determine barriers and facilitators of adherence. We report number of participants who were happy with contact with study team for adherence reminders.",
        "timeFrame": "1 month"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 4,
      "secondaryCount": 3,
      "otherCount": 0,
      "totalCount": 7
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": true,
      "isMasked": true,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 84,
    "complexityCategory": "Highly Complex"
  },
  "collectionDate": "2025-09-22T02:29:13.631Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}